Hidradenitis secondary to nirogacestat, a recently approved desmoid tumor medication

Saved in:
Bibliographic Details
Main Authors: Travis C. Frantz, MD, David Kirwin, MD, Catherine Brahe, MD
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:JAAD Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352512624005137
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832589964400918528
author Travis C. Frantz, MD
David Kirwin, MD
Catherine Brahe, MD
author_facet Travis C. Frantz, MD
David Kirwin, MD
Catherine Brahe, MD
author_sort Travis C. Frantz, MD
collection DOAJ
format Article
id doaj-art-26616dc8fdc94c4c8f6910d831eba0e8
institution Kabale University
issn 2352-5126
language English
publishDate 2025-03-01
publisher Elsevier
record_format Article
series JAAD Case Reports
spelling doaj-art-26616dc8fdc94c4c8f6910d831eba0e82025-01-24T04:45:23ZengElsevierJAAD Case Reports2352-51262025-03-015712Hidradenitis secondary to nirogacestat, a recently approved desmoid tumor medicationTravis C. Frantz, MD0David Kirwin, MD1Catherine Brahe, MD2Correspondence to: Travis C. Frantz, MD, Department of Dermatology, Navy Medical Readiness Training Center San Diego, 34800 Bob Wilson Dr, San Diego, CA 92134.; Department of Dermatology, Navy Medicine Readiness and Training Command San Diego, San Diego, CaliforniaDepartment of Dermatology, Navy Medicine Readiness and Training Command San Diego, San Diego, CaliforniaDepartment of Dermatology, Navy Medicine Readiness and Training Command San Diego, San Diego, Californiahttp://www.sciencedirect.com/science/article/pii/S2352512624005137cutaneous drug reactiondesmoid tumorgamma secretase inhibitorhidradenitishidradenitis suppurativaHS
spellingShingle Travis C. Frantz, MD
David Kirwin, MD
Catherine Brahe, MD
Hidradenitis secondary to nirogacestat, a recently approved desmoid tumor medication
JAAD Case Reports
cutaneous drug reaction
desmoid tumor
gamma secretase inhibitor
hidradenitis
hidradenitis suppurativa
HS
title Hidradenitis secondary to nirogacestat, a recently approved desmoid tumor medication
title_full Hidradenitis secondary to nirogacestat, a recently approved desmoid tumor medication
title_fullStr Hidradenitis secondary to nirogacestat, a recently approved desmoid tumor medication
title_full_unstemmed Hidradenitis secondary to nirogacestat, a recently approved desmoid tumor medication
title_short Hidradenitis secondary to nirogacestat, a recently approved desmoid tumor medication
title_sort hidradenitis secondary to nirogacestat a recently approved desmoid tumor medication
topic cutaneous drug reaction
desmoid tumor
gamma secretase inhibitor
hidradenitis
hidradenitis suppurativa
HS
url http://www.sciencedirect.com/science/article/pii/S2352512624005137
work_keys_str_mv AT traviscfrantzmd hidradenitissecondarytonirogacestatarecentlyapproveddesmoidtumormedication
AT davidkirwinmd hidradenitissecondarytonirogacestatarecentlyapproveddesmoidtumormedication
AT catherinebrahemd hidradenitissecondarytonirogacestatarecentlyapproveddesmoidtumormedication